Cargando…
A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations
Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different so...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385593/ https://www.ncbi.nlm.nih.gov/pubmed/32719490 http://dx.doi.org/10.1038/s41598-020-69351-x |
_version_ | 1783563817088712704 |
---|---|
author | Jankowiak, Łukasz Rozsa, Lajos Tryjanowski, Piotr Møller, Anders Pape |
author_facet | Jankowiak, Łukasz Rozsa, Lajos Tryjanowski, Piotr Møller, Anders Pape |
author_sort | Jankowiak, Łukasz |
collection | PubMed |
description | Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different societies but the factors underlying this variability are not known. Given that prevalence of toxoplasmosis in human societies may serve as a proxy for hygiene, and it also exerts both direct and immune-mediated antiviral effects, we hypothesize a negative covariation between toxoplasmosis and measures of the CoVID-19 pandemic across countries. We obtained aged-adjusted toxoplasmosis prevalence of pregnant women from the literature. Since the differences in the CoVID-19 morbidity and mortality may depend on the different timing of the epidemics in each country, we applied the date of first documented CoVID-19 in each country as a proxy of susceptibility, with a statistical control for population size effects. Using these two indices, we show a highly significant negative co-variation between the two pandemics across 86 countries. Then, considering that the wealth of nations often co-varies with the prevalence of diseases, we introduced GDP per capita into our model. The prevalence of toxoplasmosis co-varies negatively, while the date of first CoVID-19 co-varies positively with GDP per capita across countries. Further, to control for the strong spatial autocorrelation among countries, we carried out a Spatial Structure Analyses of the relationships between the date of first CoVID-19, prevalence of toxoplasmosis, and GDP per capita. Results of this analysis did not confirm a direct causal relationship between toxoplasmosis and susceptibility to the CoVID-19 pandemics. As far as an analysis of observational data let us to suggest, it appears that the interaction between CoVID-19 and toxoplasmosis is mediated by GDP per capita and spatial effects. This prompts the question whether the formerly known covariations of CoVID-19 and BCG vaccination or air pollution might have also emerged as spurious indirect effects. |
format | Online Article Text |
id | pubmed-7385593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73855932020-07-29 A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations Jankowiak, Łukasz Rozsa, Lajos Tryjanowski, Piotr Møller, Anders Pape Sci Rep Article Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different societies but the factors underlying this variability are not known. Given that prevalence of toxoplasmosis in human societies may serve as a proxy for hygiene, and it also exerts both direct and immune-mediated antiviral effects, we hypothesize a negative covariation between toxoplasmosis and measures of the CoVID-19 pandemic across countries. We obtained aged-adjusted toxoplasmosis prevalence of pregnant women from the literature. Since the differences in the CoVID-19 morbidity and mortality may depend on the different timing of the epidemics in each country, we applied the date of first documented CoVID-19 in each country as a proxy of susceptibility, with a statistical control for population size effects. Using these two indices, we show a highly significant negative co-variation between the two pandemics across 86 countries. Then, considering that the wealth of nations often co-varies with the prevalence of diseases, we introduced GDP per capita into our model. The prevalence of toxoplasmosis co-varies negatively, while the date of first CoVID-19 co-varies positively with GDP per capita across countries. Further, to control for the strong spatial autocorrelation among countries, we carried out a Spatial Structure Analyses of the relationships between the date of first CoVID-19, prevalence of toxoplasmosis, and GDP per capita. Results of this analysis did not confirm a direct causal relationship between toxoplasmosis and susceptibility to the CoVID-19 pandemics. As far as an analysis of observational data let us to suggest, it appears that the interaction between CoVID-19 and toxoplasmosis is mediated by GDP per capita and spatial effects. This prompts the question whether the formerly known covariations of CoVID-19 and BCG vaccination or air pollution might have also emerged as spurious indirect effects. Nature Publishing Group UK 2020-07-27 /pmc/articles/PMC7385593/ /pubmed/32719490 http://dx.doi.org/10.1038/s41598-020-69351-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Jankowiak, Łukasz Rozsa, Lajos Tryjanowski, Piotr Møller, Anders Pape A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations |
title | A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations |
title_full | A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations |
title_fullStr | A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations |
title_full_unstemmed | A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations |
title_short | A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations |
title_sort | negative covariation between toxoplasmosis and covid-19 with alternative interpretations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385593/ https://www.ncbi.nlm.nih.gov/pubmed/32719490 http://dx.doi.org/10.1038/s41598-020-69351-x |
work_keys_str_mv | AT jankowiakłukasz anegativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT rozsalajos anegativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT tryjanowskipiotr anegativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT mølleranderspape anegativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT jankowiakłukasz negativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT rozsalajos negativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT tryjanowskipiotr negativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations AT mølleranderspape negativecovariationbetweentoxoplasmosisandcovid19withalternativeinterpretations |